Lack of SIRP ‐alpha reduces lung cancer growth in mice by promoting anti‐tumour ability of macrophages and neutrophils
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lack of
SIRP
‐alpha reduces lung cancer growth in mice by promoting anti‐tumour ability of macrophages and neutrophils
Authors
Keywords
-
Journal
CELL PROLIFERATION
Volume 56, Issue 2, Pages -
Publisher
Wiley
Online
2022-11-24
DOI
10.1111/cpr.13361
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Soluble SIRP-Alpha Promotes Murine Acute Lung Injury Through Suppressing Macrophage Phagocytosis
- (2022) Qinjun Shen et al. Frontiers in Immunology
- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- SCARF1 promotes M2 polarization of Kupffer cells via calcium‐dependent PI3K‐AKT‐STAT3 signalling to improve liver transplantation
- (2021) Xue‐song Xu et al. CELL PROLIFERATION
- PDLIM2 repression by ROS in alveolar macrophages promotes lung tumorigenesis
- (2021) Liwen Li et al. JCI Insight
- Cholesterol-Induced M4-Like Macrophages Recruit Neutrophils and Induce NETosis
- (2021) Ana C. Maretti-Mira et al. Frontiers in Immunology
- EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation
- (2021) Ying Li et al. BMC Pulmonary Medicine
- Activation of Toll-like receptor 2 enhances peripheral and tumor-infiltrating CD8+ T cell cytotoxicity in patients with gastric cancer
- (2021) Junli Xu et al. BMC IMMUNOLOGY
- Anti‐Lung Cancer Activities of 1,2,3‐Triazole Curcumin Derivatives via Regulation of the MAPK/NF‐κB/STAT3 Signaling Pathways
- (2021) Tai Xin Zhi et al. ChemMedChem
- Low‑doses of aspirin promote the growth of human PC‑9 lung cancer cells through activation of the MAPK family
- (2021) Yue Qian et al. Experimental and Therapeutic Medicine
- TR35 Exerts Anti-tumor Effects by Modulating Mitogen-Activated Protein Kinase and STAT3 Signaling in Lung Cancer Cells
- (2021) Zhiyong Shi et al. Frontiers in Cell and Developmental Biology
- Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC
- (2020) Annunziata Nigro et al. Frontiers in Immunology
- CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis
- (2020) Meghan A. Morrissey et al. IMMUNITY
- Dioscin elicits anti‐tumour immunity by inhibiting macrophage M2 polarization via JNK and STAT3 pathways in lung cancer
- (2020) Luyun Cui et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Selective SIRPα blockade reverses tumor T cell exclusion and overcomes cancer immunotherapy resistance
- (2020) Vanessa Gauttier et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer
- (2020) R. Perets et al. ANNALS OF ONCOLOGY
- IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy
- (2020) Rebekka Weber et al. CELLULAR IMMUNOLOGY
- HoxA10 Facilitates SHP-1-Catalyzed Dephosphorylation of p38 MAPK/STAT3 To Repress Hepatitis B Virus Replication by a Feedback Regulatory Mechanism
- (2019) Qingyu Yang et al. JOURNAL OF VIROLOGY
- RRx-001 Acts as a Dual Small Molecule Checkpoint Inhibitor by Downregulating CD47 on Cancer Cells and SIRP-α on Monocytes/Macrophages
- (2019) Pedro Cabrales Translational Oncology
- The Tumor Microenvironment Innately Modulates Cancer Progression
- (2019) Dominique C. Hinshaw et al. CANCER RESEARCH
- Neutrophil Heterogeneity in Cancer: From Biology to Therapies
- (2019) Pacôme Lecot et al. Frontiers in Immunology
- Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation
- (2019) Anthony L. Schwartz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer
- (2019) Xuyao Zhang et al. Journal for ImmunoTherapy of Cancer
- Tribbles homolog 1 deficiency modulates function and polarization of murine bone marrow–derived macrophages
- (2018) Lilli Arndt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma
- (2018) Zi Yin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Macrophage plasticity, polarization, and function in health and disease
- (2018) Abbas Shapouri-Moghaddam et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity
- (2017) Nan Guo Ring et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of STAT3- and MAPK-dependent PGE2 synthesis ameliorates phagocytosis of fibrillar β-amyloid peptide (1-42) via EP2 receptor in EMF-stimulated N9 microglial cells
- (2016) Gen-Lin He et al. Journal of Neuroinflammation
- Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment
- (2016) Jaehong Kim et al. MEDIATORS OF INFLAMMATION
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of interleukin-6 in cancer progression and therapeutic resistance
- (2016) Neeraj Kumari et al. TUMOR BIOLOGY
- Neutrophils recruit regulatory T-cells into tumorsviasecretion of CCL17-A new mechanism of impaired antitumor immunity
- (2014) Inbal Mishalian et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
- (2014) Evgeniy B. Eruslanov et al. JOURNAL OF CLINICAL INVESTIGATION
- Keratin pearl degradation in oral squamous cell carcinoma: reciprocal roles of neutrophils and macrophages
- (2014) Ahmed A. M. Essa et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- IL-10: Master Switch from Tumor-Promoting Inflammation to Antitumor Immunity
- (2014) M. Oft Cancer Immunology Research
- The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic Target
- (2013) A. Neil Barclay et al. Annual Review of Immunology
- Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation
- (2013) K. De Filippo et al. BLOOD
- IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus
- (2013) Miao-Fen Chen et al. Molecular Cancer
- Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy
- (2012) Chin Hao Chang et al. INTERNATIONAL JOURNAL OF CANCER
- Origins of tumor-associated macrophages and neutrophils
- (2012) V. Cortez-Retamozo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- Functions and molecular mechanisms of the CD47–SIRPα signalling pathway
- (2009) Takashi Matozaki et al. TRENDS IN CELL BIOLOGY
- Surfactant Proteins A and D Suppress Alveolar Macrophage Phagocytosis via Interaction with SIRPα
- (2008) William J. Janssen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started